A型主动脉夹层合并脑灌注不良的外科治疗:IRAD注册研究结果
基于国际急性主动脉夹层注册(IRAD)数据,评估A型主动脉夹层(TAAAD)合并脑灌注不良(CM)与神经功能缺损患者的手术治疗结局。2402例手术患者中362例(15.1%)存在CM伴神经功能缺损。CM组院内死亡率25.7%,高于无CM组的12.0%,但仍有近75%的患者院内生存。
要点
- TAAAD手术患者中15.1%合并脑灌注不良与神经功能缺损。
- CM组院内死亡率25.7%,显著高于无神经功能缺损者的12.0%。
- 尽管病情危重,CM组近75%患者获得院内生存,仍可考虑救命手术。
核心结论
- TAAAD合并脑灌注不良与神经功能缺损者占手术患者的15.1%,院内死亡率为25.7%,但近75%的患者获得院内生存。
- 作者认为外科医生可继续为此类危重患者提供救命手术,其并发症与死亡率处于可接受范围。
研究设计与样本
- 研究为基于国际急性主动脉夹层注册(IRAD)的手术治疗TAAAD患者评估,共纳入2402例接受手术修复的患者。
- 按是否合并脑灌注不良与神经功能缺损分为CM组362例(15.1%)与无神经功能缺损组2040例(84.9%)。
主要发现
- CM组较少表现为胸痛(66% vs 86.5%;P < .001)和背痛(35.9% vs 44.4%;P = .008)。
- CM组更常出现晕厥(48.4% vs 10.1%;P < .001)、外周灌注不良(52.7% vs 38.0%;P < .001)和休克(16.2% vs 4.1%;P < .001)。
- CM组更常见DeBakey I型(63.8% vs 47.1%;P < .001)和心包积液(53.8% vs 40.6;P < .001)。
- 两组马方综合征(2.8% vs 3.0%;P = .870)与已知主动脉瘤病史(11.7% vs 13.9%;P = .296)无差异,全弓置换比例亦无差异(21.3% vs 19.5%;P = .473)。
- CM组术后脑血管意外(17.5% vs 7.2%;P < .001)、急性肾损伤(28.3% vs 18.1%;P < .001)及院内死亡(25.7% vs 12.0%;P < .001)均更高。
临床怎么用
- 对TAAAD合并脑灌注不良与神经功能缺损的危重患者,在充分评估与沟通后仍可考虑急诊救命手术。
- 围术期应警惕术后脑血管意外与急性肾损伤风险升高,并针对休克、心包积液等表现做好准备。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The strategy for intervention remains controversial for patients presenting with type A aortic dissection (TAAAD) and cerebral malperfusion with neurologic deficit. METHODS: Surgically managed patients with TAAAD enrolled in the International Registry of Acute Aortic Dissection were evaluated to determine the incidence and prognosis of patients with cerebral malperfusion. RESULTS: A total of 2402 patients underwent surgical repair of TAAAD. Of these, 362 (15.1%) presented with cerebral malperfusion (CM) and neurologic deficits, and 2040 (84.9%) patients had no neurologic deficits at presentation. Patients with CM were more less likely to present with chest pain (66% vs 86.5%; P < .001) and back pain (35.9% vs 44.4%; P = .008). Patients with CM were more likely to present with syncope (48.4% vs 10.1%; P < .001), peripheral malperfusion (52.7% vs 38.0%; P < .001), and shock (16.2% vs 4.1%; P < .001). There was no difference in the incidence of Marfan syndrome (2.8% vs 3.0%; P = .870) or history of known aortic aneurysm (11.7% vs 13.9%; P = .296). Patients with CM were more likely to have a DeBakey I (63.8% vs 47.1%; P < .001) and a pericardial effusion (53.8% vs 40.6; P < .001) on presentation. There was no difference in total arch replacement (21.3% for CM vs 19.5% for no CM; P = .473). Patients with CM had an increased incidence of postoperative cerebrovascular accident (17.5% vs 7.2%; P < .001) and acute kidney injury (28.3% vs 18.1%; P < .001). In-hospital mortality was greater in patients with CM (25.7% vs 12.0%; P < .001). CONCLUSIONS: Fifteen percent of patients with TAAAD presented with CM and neurologic deficits. Despite the fact that this subset of the population was older and more likely to present with peripheral malperfusion, cardiac tamponade, and in shock, in-hospital survival was noted in nearly 75% of the patients. Surgeons may continue to offer lifesaving surgery for TAAAD to this critically ill cohort of patients with acceptable morbidity and mortality.
引用
- Sultan I, Bianco V, Patel HJ, et al. Surgery for type A aortic dissection in patients with cerebral malperfusion: Results from the International Registry of Acute Aortic Dissection. J Thorac Cardiovasc Surg. 2019. PMID: 31959445. doi:10.1016/j.jtcvs.2019.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。